Annual Retained Earnings
-$2.68 B
-$151.58 M-5.99%
31 December 2023
Summary:
Amicus Therapeutics annual retained earnings is currently -$2.68 billion, with the most recent change of -$151.58 million (-5.99%) on 31 December 2023. During the last 3 years, it has fallen by -$388.15 million (-16.91%). FOLD annual retained earnings is now -31466.20% below its all-time high of -$8.50 million, reached on 31 December 2003.FOLD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$2.75 B
-$6.73 M-0.24%
30 September 2024
Summary:
Amicus Therapeutics quarterly retained earnings is currently -$2.75 billion, with the most recent change of -$6.73 million (-0.24%) on 30 September 2024. Over the past year, it has dropped by -$70.84 million (-2.64%). FOLD quarterly retained earnings is now -7281.41% below its all-time high of -$37.32 million, reached on 31 December 2005.FOLD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FOLD Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -2.6% |
| 3 y3 years | -16.9% | -20.0% |
| 5 y5 years | -51.8% | -55.8% |
FOLD Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.9% | at low | -20.0% | at low |
| 5 y | 5 years | -51.8% | at low | -55.8% | at low |
| alltime | all time | <-9999.0% | at low | -7281.4% | at low |
Amicus Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$2.75 B(+0.2%) |
| June 2024 | - | -$2.75 B(+0.6%) |
| Mar 2024 | - | -$2.73 B(+1.8%) |
| Dec 2023 | -$2.68 B(+6.0%) | -$2.68 B(+1.3%) |
| Sept 2023 | - | -$2.65 B(+0.8%) |
| June 2023 | - | -$2.63 B(+1.7%) |
| Mar 2023 | - | -$2.59 B(+2.1%) |
| Dec 2022 | -$2.53 B(+10.3%) | -$2.53 B(+2.3%) |
| Sept 2022 | - | -$2.48 B(+1.4%) |
| June 2022 | - | -$2.44 B(+2.6%) |
| Mar 2022 | - | -$2.38 B(+3.7%) |
| Dec 2021 | -$2.30 B(+12.2%) | -$2.30 B(+3.8%) |
| Sept 2021 | - | -$2.21 B(+2.3%) |
| June 2021 | - | -$2.16 B(+2.4%) |
| Mar 2021 | - | -$2.11 B(+3.2%) |
| Dec 2020 | -$2.05 B(+15.7%) | -$2.05 B(+3.6%) |
| Sept 2020 | - | -$1.97 B(+3.4%) |
| June 2020 | - | -$1.91 B(+2.8%) |
| Mar 2020 | - | -$1.86 B(+5.0%) |
| Dec 2019 | -$1.77 B(+25.2%) | -$1.77 B(+5.3%) |
| Sept 2019 | - | -$1.68 B(+3.8%) |
| June 2019 | - | -$1.62 B(+5.5%) |
| Mar 2019 | - | -$1.53 B(+8.5%) |
| Dec 2018 | -$1.41 B(+32.8%) | -$1.41 B(+5.9%) |
| Sept 2018 | - | -$1.33 B(+13.5%) |
| June 2018 | - | -$1.17 B(+5.6%) |
| Mar 2018 | - | -$1.11 B(+4.7%) |
| Dec 2017 | -$1.06 B(+36.4%) | -$1.06 B(+7.0%) |
| Sept 2017 | - | -$994.40 M(+12.6%) |
| June 2017 | - | -$882.74 M(+5.8%) |
| Mar 2017 | - | -$834.60 M(+7.1%) |
| Dec 2016 | -$779.61 M(+34.5%) | -$779.61 M(+8.1%) |
| Sept 2016 | - | -$720.96 M(+6.9%) |
| June 2016 | - | -$674.31 M(+8.2%) |
| Mar 2016 | - | -$623.26 M(+7.5%) |
| Dec 2015 | -$579.57 M | -$579.57 M(+8.0%) |
| Sept 2015 | - | -$536.67 M(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | -$498.87 M(+5.8%) |
| Mar 2015 | - | -$471.74 M(+5.4%) |
| Dec 2014 | -$447.45 M(+18.2%) | -$447.45 M(+5.0%) |
| Sept 2014 | - | -$426.23 M(+4.2%) |
| June 2014 | - | -$409.08 M(+3.7%) |
| Mar 2014 | - | -$394.46 M(+4.2%) |
| Dec 2013 | -$378.52 M(+18.7%) | -$378.52 M(+3.3%) |
| Sept 2013 | - | -$366.29 M(+4.1%) |
| June 2013 | - | -$351.70 M(+4.6%) |
| Mar 2013 | - | -$336.35 M(+5.5%) |
| Dec 2012 | -$318.89 M(+18.1%) | -$318.89 M(+3.2%) |
| Sept 2012 | - | -$308.87 M(+5.6%) |
| June 2012 | - | -$292.58 M(+3.3%) |
| Mar 2012 | - | -$283.24 M(+4.9%) |
| Dec 2011 | -$270.10 M(+19.7%) | -$270.10 M(+3.3%) |
| Sept 2011 | - | -$261.44 M(+3.9%) |
| June 2011 | - | -$251.68 M(+5.3%) |
| Mar 2011 | - | -$239.04 M(+5.9%) |
| Dec 2010 | -$225.69 M(+32.2%) | -$225.69 M(+7.2%) |
| Sept 2010 | - | -$210.60 M(+7.9%) |
| June 2010 | - | -$195.25 M(+6.2%) |
| Mar 2010 | - | -$183.93 M(+7.7%) |
| Dec 2009 | -$170.76 M(+4.0%) | -$170.76 M(-16.2%) |
| Sept 2009 | - | -$203.71 M(+7.1%) |
| June 2009 | - | -$190.28 M(+7.7%) |
| Mar 2009 | - | -$176.66 M(+7.6%) |
| Dec 2008 | -$164.19 M(+31.5%) | -$164.19 M(+9.4%) |
| Sept 2008 | - | -$150.04 M(+5.8%) |
| June 2008 | - | -$141.86 M(+7.0%) |
| Mar 2008 | - | -$132.56 M(+6.2%) |
| Dec 2007 | -$124.83 M(+49.2%) | -$124.83 M(+10.4%) |
| Sept 2007 | - | -$113.06 M(+10.0%) |
| June 2007 | - | -$102.76 M(+10.1%) |
| Mar 2007 | - | -$93.36 M(+11.6%) |
| Dec 2006 | -$83.67 M(+124.2%) | -$83.67 M(+124.2%) |
| Dec 2005 | -$37.32 M(+338.9%) | -$37.32 M |
| Dec 2003 | -$8.50 M | - |
FAQ
- What is Amicus Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly retained earnings year-on-year change?
What is Amicus Therapeutics annual retained earnings?
The current annual retained earnings of FOLD is -$2.68 B
What is the all time high annual retained earnings for Amicus Therapeutics?
Amicus Therapeutics all-time high annual retained earnings is -$8.50 M
What is Amicus Therapeutics quarterly retained earnings?
The current quarterly retained earnings of FOLD is -$2.75 B
What is the all time high quarterly retained earnings for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly retained earnings is -$37.32 M
What is Amicus Therapeutics quarterly retained earnings year-on-year change?
Over the past year, FOLD quarterly retained earnings has changed by -$70.84 M (-2.64%)